Malaria elimination in Sub-Saharan Africa: essential tools and identifiable targets
Malaria elimination in Sub-Saharan Africa: essential tools and identifiable targets
批准号:
MC_EX_MR/J002364/1
负责人:
Umberto D'Alessandro
金额:
$254.84万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2012
资助国家:
英国
项目状态:
已结题
起止时间:
2012 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Though still affecting an important proportion of the world population, malaria has declined substantially in the last few years, thanks also to the scale up of interventions such as bed nets treated with insecticide. Such decrease has been observed also in sub-Saharan African countries, including The Gambia, where the malaria burden is the highest. The idea that malaria can be reduced at the point where it would not be a major public health problem anymore or would even be eliminated has been re-introduced again after the previous attempt in the 1950s. This was abandoned mainly for two reasons: lack of financial support and use of a single strategy that did not take into account the extreme variability of malaria transmission. It is now recognised that the knowledge needed to support any elimination effort is limited and that a new attempt in this direction should be supported by a strong research component. This proposed research program to be carried out in The Gambia aims at providing sub-Saharan African National Malaria Control Programs with the necessary knowledge and tools to move farther, towards malaria elimination. The Gambia is the ideal place to carry out the proposed research program because 1. The country has been extremely successful in reducing the malaria burden and aims at reducing it further; 2. The MRC laboratories have the required expertise, the advanced technological platform and the necessary international collaborations to achieve the program's objectives. The combination of these two factors is unique in West Africa and offers a golden opportunity to carry out a research programme that can have a profound influence on the way elimination efforts will be implemented in sub-Saharan Africa. Activities are divided into two parallel and complementary sections: one section aims at understanding the dynamics of malaria transmission and the reasons why this can substantially differ within few kilometres; the other section will aim at improving diagnostic tests able to identify malaria infected but otherwise healthy people (malaria carriers). For the former, the populations of 12 villages will be intensively followed up for 3 transmission seasons to understand who the malaria carriers are and how the infection spreads across the populations. Information on the vector population, including the presence of insecticide resistance, and on the human behaviour will be collected to partly explain the likely differences between the study villages. At the end of the study we will have a better understanding on how the malaria parasites spread and what are the important determinants that maintain transmission from one year to the other, despite the high coverage of preventive and curative measures.Concerning diagnostic tests, the currently available tests that can be used in the field cannot detect a proportion of infected people that contributes in maintaining transmission. We will try two approaches, one aiming at developing easy-to-use molecular test that can detect most infected individuals, and the other looking at "markers" of infection by detecting parasite's or host's proteins that can be found only in infected individuals. The latter could provide the knowledge necessary to develop a more sensitive test. The results of this research program will be important for any sub-Saharan African country willing to go towards elimination of malaria. They will be disseminated through international and regional conferences, and by international peer-reviewed publications and communications. In addition, through the Gambian National Malaria Control Program, results may be disseminated through the local press in a form accessible to a wider public.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1093/cid/ciy870
发表时间:
2019-07-02
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
[Mwesigwa J, Achan J, Affara M, Wathuo M, Worwui A, Mohammed NI, Kanuteh F, Prom A, Dierickx S, di Tanna GL, Nwakanma D, Bousema T, Drakeley C, Van Geertruyden JP, D'Alessandro U]
通讯作者:
D'Alessandro U
DOI:
10.1371/journal.pone.0187059
发表时间:
2017
期刊:
PloS one
影响因子:
3.7
作者:
[Mwesigwa J, Achan J, Di Tanna GL, Affara M, Jawara M, Worwui A, Hamid-Adiamoh M, Kanuteh F, Ceesay S, Bousema T, Drakeley C, Grietens KP, Lindsay SW, Van Geertruyden JP, D'Alessandro U]
通讯作者:
D'Alessandro U
DOI:
10.1186/s12936-016-1255-0
发表时间:
2016-04-11
期刊:
MALARIA JOURNAL
影响因子:
3
作者:
[Jaiteh, Fatou, Dierickx, Susan, Grietens, Koen Peeters]
通讯作者:
Grietens, Koen Peeters
Mass Drug Administration to Control and Eliminate Malaria in Africa: How Do We Best Utilize the Tools at Hand?
在非洲控制和消除疟疾的大规模药物管理:我们如何最好地利用手头的工具?
DOI:
10.1093/cid/ciy871
发表时间:
2019
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
[Guler,JenniferL, Rosenthal,PhilipJ]
通讯作者:
Rosenthal,PhilipJ
DOI:
10.1371/journal.pone.0148627
发表时间:
2016
期刊:
PloS one
影响因子:
3.7
作者:
[Dierickx S, Gryseels C, Mwesigwa J, O'Neill S, Bannister-Tyrell M, Ronse M, Jaiteh F, Gerrets R, D'Alessandro U, Grietens KP]
通讯作者:
Grietens KP
共 9 条
ICF: Seasonal R21 mass vaccination for malaria elimination
-
批准号:MR/Y00468X/1
-
项目类别:Research Grant
-
资助金额:$365.72万
-
财政年份:2023
-
负责人:Umberto D'Alessandro
-
依托单位:
Research Services Theme
-
批准号:MC_UU_00031/9
-
项目类别:Intramural
-
资助金额:$1433.09万
-
财政年份:2022
-
负责人:Umberto D'Alessandro
-
依托单位:
Operations and Infrastructure
-
批准号:MC_UU_00031/12
-
项目类别:Intramural
-
资助金额:$1771.27万
-
财政年份:2022
-
负责人:Umberto D'Alessandro
-
依托单位:
West Africa Health Data Research Platform
-
批准号:MC_PC_20048
-
项目类别:Intramural
-
资助金额:$12.08万
-
财政年份:2021
-
负责人:Umberto D'Alessandro
-
依托单位:
COVID19 Strategic Priorities: SUPPLEMENTARY FUNDING OFFER FOR THE MRC UNIT, THE GAMBIA AT LSHTM (MRC Unit, The Gambia)
-
批准号:MC_PC_20054
-
项目类别:Intramural
-
资助金额:$76.95万
-
财政年份:2021
-
负责人:Umberto D'Alessandro
-
依托单位:
Building Genomics sequencing competency across West African partners
-
批准号:MC_PC_20045
-
项目类别:Intramural
-
资助金额:$12.61万
-
财政年份:2021
-
负责人:Umberto D'Alessandro
-
依托单位:
Enhancing regional genomic surveillance of malaria for elimination planning
-
批准号:MC_PC_20037
-
项目类别:Intramural
-
资助金额:$12.61万
-
财政年份:2021
-
负责人:Umberto D'Alessandro
-
依托单位:
The Impact of ambient air pollution on infectious disease outcomes in West Africa
-
批准号:MC_PC_20038
-
项目类别:Intramural
-
资助金额:$8.22万
-
财政年份:2021
-
负责人:Umberto D'Alessandro
-
依托单位:
COVID-19: award for MRC Unit The Gambia at LSHTM
-
批准号:MC_PC_19061
-
项目类别:Intramural
-
资助金额:$86.01万
-
财政年份:2020
-
负责人:Umberto D'Alessandro
-
依托单位:
Supplementary Award to MRC Gambia for Genomics in Africa
-
批准号:MC_PC_19028
-
项目类别:Intramural
-
资助金额:$108.31万
-
财政年份:2020
-
负责人:Umberto D'Alessandro
-
依托单位:
SUPPLEMENTARY FUNDING OFFER FOR THE MRC UNIT, THE GAMBIA AT LSHTM (resource to support a clinical trial of Hydroxychloroquine and Azithromycin, studies on the transmission and antibody dynamics to SARS-CoV-2 infection, and to further support
-
批准号:MC_PC_19084
-
项目类别:Intramural
-
资助金额:$560.65万
-
财政年份:2020
-
负责人:Umberto D'Alessandro
-
依托单位:
Gambia - Operations and Infrastructure
-
批准号:MC_UU_00026/7
-
项目类别:Intramural
-
资助金额:$2109.57万
-
财政年份:2018
-
负责人:Umberto D'Alessandro
-
依托单位:
Gambia - Research Services Theme
-
批准号:MC_UU_00026/6
-
项目类别:Intramural
-
资助金额:$1126.38万
-
财政年份:2018
-
负责人:Umberto D'Alessandro
-
依托单位:
Mass drug administration of ivermectin and dihydroartemisinin-piperaquine as an additional intervention for malaria elimination
-
批准号:MC_EX_MR/R006075/1
-
项目类别:Research Grant
-
资助金额:$262.18万
-
财政年份:2017
-
负责人:Umberto D'Alessandro
-
依托单位:
Reactive household-based self-administered treatment against residual malaria transmission: a cluster randomised trial
-
批准号:MC_EX_MR/N006100/1
-
项目类别:Research Grant
-
资助金额:$231.68万
-
财政年份:2015
-
负责人:Umberto D'Alessandro
-
依托单位:
Primaquine's gametocytocidal efficacy in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine
-
批准号:MC_EX_MR/K007203/1
-
项目类别:Research Grant
-
资助金额:$115.95万
-
财政年份:2012
-
负责人:Umberto D'Alessandro
-
依托单位:
海外基金